All issues
Predecessor
Volume 53, Issue 2
Displaying 1-5 of 5 articles from this issue
- |<
- <
- 1
- >
- >|
-
AKIO URABE, KATSUNORI AOKI, KIYOSHI KITAMURA, KAZUO OSHIMI, YASUNOBU K ...2000 Volume 53 Issue 2 Pages 61-74
Published: February 25, 2000
Released on J-STAGE: May 17, 2013
JOURNAL FREE ACCESSWe evaluated efficacy and safety of monotherapy with CZOP (1-2g×2/day) and combination therapy with CZOP (1-2g×2/day) and AMK (200mg×2/day) for infections in patients with hematological diseases. Efficacy was evaluated in 71 patients of monotherapy group and 70 patients of combination therapy group. Underlying diseases were mostly leukemia and lymphoma. Infections included sepsis, suspected sepsis, pneumonia and so on.
Efficacy in CZOP monotherapy was excellent in 21 patients (31.3%), good in 23 patients (34.3%), fair in 5 patients (7.5%) and the efficacy rate was 65.7%. On the other hand, in combination therapy, each was 14 patients (21.2%), 23 patients (34.8%), 12 patients (18.2%) and the efficacy rate was 56.1%.
Side effects such as eruption were noted in 2 patients. Abnormal laboratory findings were noted in 9 patients. All side effects as well as abnormal laboratory findings were minimal.
It was concluded that CZOP monotherapy was effective in the treatment of various infections accompanying hematological diseases.View full abstractDownload PDF (1384K) -
2000 Volume 53 Issue 2 Pages 75-133
Published: February 25, 2000
Released on J-STAGE: May 17, 2013
JOURNAL FREE ACCESSDownload PDF (51743K) -
2000 Volume 53 Issue 2 Pages C1-
Published: 2000
Released on J-STAGE: May 17, 2013
JOURNAL FREE ACCESS -
2000 Volume 53 Issue 2 Pages C1a-
Published: 2000
Released on J-STAGE: May 17, 2013
JOURNAL FREE ACCESS -
2000 Volume 53 Issue 2 Pages C2-
Published: 2000
Released on J-STAGE: May 17, 2013
JOURNAL FREE ACCESS
- |<
- <
- 1
- >
- >|